Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C47H73NO17 |
Molecular Weight | 924.079 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 19 / 19 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12C[C@@H](O[C@]3([H])O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\C=C\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2
InChI
InChIKey=APKFDSVGJQXUKY-INPOYWNPSA-N
InChI=1S/C47H73NO17/c1-27-17-15-13-11-9-7-5-6-8-10-12-14-16-18-34(64-46-44(58)41(48)43(57)30(4)63-46)24-38-40(45(59)60)37(54)26-47(61,65-38)25-33(51)22-36(53)35(52)20-19-31(49)21-32(50)23-39(55)62-29(3)28(2)42(27)56/h5-18,27-38,40-44,46,49-54,56-58,61H,19-26,48H2,1-4H3,(H,59,60)/b6-5+,9-7+,10-8+,13-11+,14-12+,17-15+,18-16+/t27-,28-,29-,30+,31+,32+,33-,34-,35+,36+,37-,38-,40+,41-,42+,43+,44-,46-,47+/m0/s1
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QJ02AA01
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
||
|
NDF-RT |
N0000175498
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
||
|
FDA ORPHAN DRUG |
315310
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
6.5.2
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
||
|
WHO-ATC |
G01AA03
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
||
|
FDA ORPHAN DRUG |
416113
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
||
|
WHO-VATC |
QG01AA03
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
||
|
NDF-RT |
N0000175510
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
||
|
WHO-ATC |
J02AA01
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
||
|
FDA ORPHAN DRUG |
99496
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
||
|
WHO-VATC |
QA07AA07
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
||
|
FDA ORPHAN DRUG |
210805
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
||
|
FDA ORPHAN DRUG |
57891
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
||
|
WHO-ATC |
A07AA07
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
||
|
FDA ORPHAN DRUG |
99696
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
||
|
FDA ORPHAN DRUG |
97796
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
||
|
WHO-ATC |
A01AB04
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
||
|
FDA ORPHAN DRUG |
97396
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
||
|
WHO-VATC |
QA01AB04
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
||
|
FDA ORPHAN DRUG |
97696
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
||
|
FDA ORPHAN DRUG |
97096
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
6.3
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
||
|
FDA ORPHAN DRUG |
96996
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
||
|
NCI_THESAURUS |
C514
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
||
|
FDA ORPHAN DRUG |
703119
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
||
|
NDF-RT |
N0000007672
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
||
|
FDA ORPHAN DRUG |
99596
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
||
|
LIVERTOX |
NBK548141
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
236594
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
ALTERNATIVE | |||
|
2001759
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
ALTERNATIVE | |||
|
215-742-2
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
PRIMARY | |||
|
527017
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
PRIMARY | |||
|
197
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
PRIMARY | |||
|
AMPHOTERICIN B
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
PRIMARY | |||
|
732
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
PRIMARY | |||
|
AMPHOTERICIN B
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
PRIMARY | Description: A yellow to orange powder; odourless or almost odourless. Solubility: Practically insoluble in water, ethanol (~750 g/l) TS, toluene R and ether R; soluble in 200 parts of dimethylformamide R and in 20 parts of dimethyl sulfoxide R, slightly soluble in methanol R. Category: Antifungal drug. Storage: Amphotericin B should be kept in a tightly closed container, protected from light, and stored at a temperature between 2 and 8 ?C. Labelling: The designation Amphotericin B for parenteral use indicates that the substance complies with the altered and additional requirements for Amphotericin B and may be used for parenteral administration. Additional information: Even in the absence of light, Amphotericin B is gradually degraded on exposure to a humid atmosphere, the decomposition being faster at higher temperatures. In diluted solutions it is sensitive to light and is inactivated at low pH values. Definition: Amphotericin B contains not less than 750 μg per mg, calculated with reference to the dried substance. | ||
|
2682
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
PRIMARY | |||
|
1032007
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
PRIMARY | |||
|
CHEMBL267345
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
PRIMARY | |||
|
7XU7A7DROE
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
PRIMARY | |||
|
SUB05486MIG
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
PRIMARY | |||
|
SUB20545
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
PRIMARY | |||
|
DTXSID9022601
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
PRIMARY | |||
|
869
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
PRIMARY | |||
|
5280965
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
PRIMARY | |||
|
SUB12887MIG
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
PRIMARY | |||
|
7XU7A7DROE
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
PRIMARY | |||
|
DB00681
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
PRIMARY | |||
|
SUB119245
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
PRIMARY | |||
|
C238
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
PRIMARY | |||
|
D000666
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
PRIMARY | |||
|
42527
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
ALTERNATIVE | |||
|
100000092100
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
PRIMARY | |||
|
m1852
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
PRIMARY | Merck Index | ||
|
3008
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
PRIMARY | |||
|
Amphotericin B
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
PRIMARY | |||
|
1397-89-3
Created by
admin on Fri Dec 15 15:02:58 UTC 2023 , Edited by admin on Fri Dec 15 15:02:58 UTC 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)